APA (7th ed.) Citation

R, T., D, Ž., E, T., A, P., T, J., M, R., . . . B, P. (2022). Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research, 28(21), 4771. https://doi.org/10.1158/1078-0432.CCR-22-1594

Chicago Style (17th ed.) Citation

R, Termini, et al. "Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 28, no. 21 (2022): 4771. https://doi.org/10.1158/1078-0432.CCR-22-1594.

MLA (9th ed.) Citation

R, Termini, et al. "Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 28, no. 21, 2022, p. 4771, https://doi.org/10.1158/1078-0432.CCR-22-1594.